Published 6 issues per year
ISSN Print: 1040-8401
ISSN Online: 2162-6472
Indexed in
Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
ABSTRACT
Programming of inflammation resolution is governed by a class of specialized pro-resolving lipid mediators (SPMs) that act in concert to modulate epithelial, endothelial, and immune cell function for restoration of homeostasis. The resolution circuits are altered in obesity and associated morbidities, including type 2 diabetes mellitus (T2D), through reduced production and/or action of SPMs, which can be rescued by therapeutic SPM delivery or up-regulation of SPM receptors. Resolvin E1 (RvE1), an eicosapentaenoic acid derivative, has potent pro-resolving and insulin-sensitizing actions mediated by BLT1 and ERV1 receptors in the vasculature and metabolic organs. Nonetheless, the RvE1-mediated increase in protective adipokines such as adiponectin in white adipose tissues, the enhancement of monocyte patrolling function in the vasculature, as well as the macrophage-clearing functions improve metabolic control in obese-prone conditions. RvE1-enhanced resolving function in obesity prevents dysbiosis of the gut microflora and increased gut permeability. These functions suggest that RE1 has therapeutic potential for immunometabolic alterations associated with T2D in patients with reduced inflammation resolving capacity. SPM profiling in individuals at risk for T2D and associated complications will help to advance personalized disease management and precision medicine.
-
Doyle Ross, Godson Catherine, Brennan Eoin, Promoting resolution in kidney disease, Current Opinion in Nephrology and Hypertension, 29, 1, 2020. Crossref
-
Sima Corneliu, Viniegra Ana, Glogauer Michael, Macrophage immunomodulation in chronic osteolytic diseases—the case of periodontitis, Journal of Leukocyte Biology, 105, 3, 2019. Crossref
-
Livshits Gregory, Kalinkovich Alexander, Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis, Ageing Research Reviews, 56, 2019. Crossref
-
Bruschi Maurizio, Santucci Laura, Petretto Andrea, Bartolocci Martina, Marchisio Marco, Ghiggeri Gian Marco, Verrina Enrico, Ramenghi Luca A., Panfoli Isabella, Candiano Giovanni, Association between maternal omega‐3 polyunsaturated fatty acids supplementation and preterm delivery: A proteomic study, The FASEB Journal, 34, 5, 2020. Crossref
-
Xia Fangbo, He Chengwei, Ren Meng, Xu Feng-Guo, Wan Jian-Bo, Quantitative profiling of eicosanoids derived from n-6 and n-3 polyunsaturated fatty acids by twin derivatization strategy combined with LC-MS/MS in patients with type 2 diabetes mellitus, Analytica Chimica Acta, 1120, 2020. Crossref
-
Desoye G., Herrera E., Adipose tissue development and lipid metabolism in the human fetus: The 2020 perspective focusing on maternal diabetes and obesity, Progress in Lipid Research, 81, 2021. Crossref
-
Herrera Vielma Francisca, Valenzuela Rodrigo, Videla Luis A., Zúñiga-Hernández Jessica, N-3 Polyunsaturated Fatty Acids and Their Lipid Mediators as A Potential Immune–Nutritional Intervention: A Molecular and Clinical View in Hepatic Disease and Other Non-Communicable Illnesses, Nutrients, 13, 10, 2021. Crossref
-
Yang Ailin, Wu Yanjun, Yu Ganggang, Wang Haoyan, Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development, Respiratory Research, 22, 1, 2021. Crossref
-
Diaz-Rubio Gustavo Ignacio, Corona-Meraz Fernanda-Isadora, Madrigal-Ruiz Perla-Monserrat, Robles-De Anda Jesús-Aureliano, Gómez-Bañuelos Eduardo, Castro-Albarran Jorge, Flores-Alvarado Luis-Javier, Vázquez-Del Mercado Mónica, Pérez-Vázquez Felipe de Jesús, Pizano-Martínez Oscar-Enrique, Navarro-Hernández Rosa-Elena, Sánchez-Margalet Víctor, CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis, PLOS ONE, 16, 1, 2021. Crossref
-
Dasilva Gabriel, Lois Salomé, Méndez Lucía, Miralles-Pérez Bernat, Romeu Marta, Ramos-Romero Sara, Torres Josep L., Medina Isabel, Fish Oil Improves Pathway-Oriented Profiling of Lipid Mediators for Maintaining Metabolic Homeostasis in Adipose Tissue of Prediabetic Rats, Frontiers in Immunology, 12, 2021. Crossref
-
Al-Shaer Abrar E., Pal Anandita, Shaikh Saame Raza, Resolvin E1-ChemR23 Axis Regulates the Hepatic Metabolic and Inflammatory Transcriptional Landscape in Obesity at the Whole Genome and Exon Level, Frontiers in Nutrition, 8, 2021. Crossref
-
Shofler David, Rai Vikrant, Mansager Sarah, Cramer Kira, Agrawal Devendra K., Impact of resolvin mediators in the immunopathology of diabetes and wound healing, Expert Review of Clinical Immunology, 17, 6, 2021. Crossref
-
Shimizu Tomohiko, Saito Tsugumichi, Aoki‐Saito Haruka, Okada Shuichi, Ikeda Hiroyuki, Nakakura Takashi, Fukuda Hayato, Arai Syota, Fujiwara Kouichi, Nakajima Yasuyo, Horiguchi Kazuhiro, Yamada Sayaka, Ishida Emi, Hisada Takeshi, Shuto Satoshi, Yamada Masanobu, Resolvin E3 ameliorates high‐fat diet‐induced insulin resistance via the phosphatidylinositol‐3‐kinase/Akt signaling pathway in adipocytes, The FASEB Journal, 36, 3, 2022. Crossref
-
Liakh Ivan, Janczy Agata, Pakiet Alicja, Korczynska Justyna, Proczko-Stepaniak Monika, Kaska Lukasz, Sledzinski Tomasz, Mika Adriana, One-anastomosis gastric bypass modulates the serum levels of pro- and anti-inflammatory oxylipins, which may contribute to the resolution of inflammation, International Journal of Obesity, 46, 2, 2022. Crossref
-
Morita Yoshifumi, Kurano Makoto, Sakai Eri, Sawabe Motoji, Aoki Junken, Yatomi Yutaka, Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy, Journal of Lipid Research, 62, 2021. Crossref
-
Livshits Gregory, Kalinkovich Alexander, Specialized, Pro-Resolving Mediators as Potential Therapeutic Agents for Alleviating Fibromyalgia Symptomatology, Pain Medicine, 23, 5, 2022. Crossref
-
Quach Su Sheng, Zhu Alan, Lee Ryan S. B., Seymour Gregory J., Immunomodulation—What to Modulate and Why? Potential Immune Targets, Frontiers in Dental Medicine, 3, 2022. Crossref
-
Zhao Zewei, Liu Siqi, Qian Bingxiu, Zhou Lin, Shi Jianglin, Liu Junxi, Xu Lin, Yang Zhonghan, CMKLR1 senses chemerin/resolvin E1 to control adipose thermogenesis and modulate metabolic homeostasis, Fundamental Research, 2022. Crossref
-
Al‐Shaer Abrar E., Pal Anandita, Shi Qing, Carson Meredith S., Regan Jennifer, Behee Madeline, Buddenbaum Nicole, Drawdy Catie, Davis Traci, Virk Rafia, Shaikh Saame Raza, Modeling human heterogeneity of obesity with diversity outbred mice reveals a fat mass‐dependent therapeutic window for resolvin E1, The FASEB Journal, 36, 6, 2022. Crossref
-
Pal Anandita, Al‐Shaer Abrar E., Guesdon William, Torres Maria J., Armstrong Michael, Quinn Kevin, Davis Traci, Reisdorph Nichole, Neufer P. Darrell, Spangenburg Espen E., Carroll Ian, Bazinet Richard P., Halade Ganesh V., Clària Joan, Shaikh Saame Raza, Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner, The FASEB Journal, 34, 8, 2020. Crossref
-
Tajbakhsh Amir, Gheibihayat Seyed Mohammad, Karami Neda, Savardashtaki Amir, Butler Alexandra E., Rizzo Manfredi, Sahebkar Amirhossein, The regulation of efferocytosis signaling pathways and adipose tissue homeostasis in physiological conditions and obesity: Current understanding and treatment options, Obesity Reviews, 23, 10, 2022. Crossref
-
Cai Jiazheng, Liu Jing, Yan Jing, Lu Xuexia, Wang Xiaoli, Li Si, Mustafa Kamal, Wang Huihui, Xue Ying, Mustafa Manal, Kantarci Alpdogan, Xing Zhe, Impact of Resolvin D1 on the inflammatory phenotype of periodontal ligament cell response to hypoxia , Journal of Periodontal Research, 57, 5, 2022. Crossref
-
Barden Anne E., Shinde Sujata, Phillips Michael, Beilin Lawrence J., Mori Trevor A., Mediators of inflammation resolution and vasoactive eicosanoids in gestational diabetes and preeclampsia, Journal of Hypertension, 40, 11, 2022. Crossref
-
Zhang Jiawei, Liu Lan, Zhang Yaxuan, Yuan Yuan, Miao Zhijuan, Lu Kaili, Zhang Xiaojie, Ni Ruiqing, Zhang Haibing, Zhao Yuwu, Wang Xiuzhe, ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation, Redox Biology, 58, 2022. Crossref